Pola Knurowska
Research Subjects
Pola Knurowska has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Anna Czuba
Krakowska Akademia im. Andrzeja Frycza Modrzewskiego w Krakowie
2 shared publications - Julia Dubel
Medical University of Warsaw, Żwirki i Wigury Street 61, 02-091 Warsaw
2 shared publications - Klaudia Serafin
The John Paul II Specialist Hospital in Nowy Targ Szpitalna Street 14, 34-400 Nowy Targ
2 shared publications - Martyna Zielnik
Medical University of Warsaw, Żwirki i Wigury Street 61, 02-091 Warsaw
2 shared publications - Patrycja Rembisz
The Ludwik Rydygier Specialist Hospital in Cracow Złotej Jesieni Street 1, 31-826 Cracow, Poland
2 shared publications - Aleksander Wrona
Healthcare Centre in Dębica Krakowska Street 91, 39-200 Dębica
1 shared publication
Latest Publications
- Open Access
- 14 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57426
Parathyroid Adenoma - The Leading Cause of Primary Hyperparathyroidism: Case Report
Primary hyperparathyroidism is an endocrine disorder characterized by excessive secretion of parathyroid hormone (PTH) by the parathyroid glands, disproportionate to the physiological requirement for calcium concentration. This hypersecretion of PTH occurs independently of dysregulation in calcium-phosphate metabolism. The predominant etiology of primary hyperparathyroidism is the presence of a parathyroid adenoma. (7) This case report presents a 68-year-old female patient with a history of osteoporosis, diagnosed in 2019 for osteoarticular pain and hypercalcemia. The suboptimal response to standard osteoporosis treatment was an indication to expand the diagnosis of calcium-phosphate disorders accompanying osteoporosis. Diagnostic evaluation confirmed primary hyperparathyroidism due to parathyroid adenoma and appropriate therapeutic measures were subsequently implemented. This report highlights the nonspecific clinical presentation of the disease and the diagnostic difficulties associated with illness. A multidisciplinary approach to the patient is required due to the multifaceted nature of the disease.
- 14 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57426
Open AccessParathyroid Adenoma - The Leading Cause of Primary Hyperparathyroidism: Case Report
Primary hyperparathyroidism is an endocrine disorder characterized by excessive secretion of parathyroid hormone (PTH) by the parathyroid glands, disproportionate to the physiological requirement for calcium concentration. This hypersecretion of PTH occurs independently of dysregulation in calcium-phosphate metabolism. The predominant etiology of primary hyperparathyroidism is the presence of a parathyroid adenoma. (7) This case report presents a 68-year-old female patient with a history of osteoporosis, diagnosed in 2019 for osteoarticular pain and hypercalcemia. The suboptimal response to standard osteoporosis treatment was an indication to expand the diagnosis of calcium-phosphate disorders accompanying osteoporosis. Diagnostic evaluation confirmed primary hyperparathyroidism due to parathyroid adenoma and appropriate therapeutic measures were subsequently implemented. This report highlights the nonspecific clinical presentation of the disease and the diagnostic difficulties associated with illness. A multidisciplinary approach to the patient is required due to the multifaceted nature of the disease.
- Open Access
- 8 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15, 52257
Impact of maternal pharmacotherapy use during lactation on breastfeeding options and safety
Due to its unique composition, breast milk is the ideal food for the baby, as it contains all the necessary nutrients. Breastfeeding is recommended by numerous scientific societies and is associated with many immediate as well as long-term benefits for mother and child. The use of pharmacotherapy in mothers during lactation raises concerns about the adverse consequences of treatment and the health of the child due to the distribution of drugs into breast milk. The following paper aims to present the safety profile of selected drug products during breastfeeding.
- 8 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15, 52257
Open AccessImpact of maternal pharmacotherapy use during lactation on breastfeeding options and safety
Due to its unique composition, breast milk is the ideal food for the baby, as it contains all the necessary nutrients. Breastfeeding is recommended by numerous scientific societies and is associated with many immediate as well as long-term benefits for mother and child. The use of pharmacotherapy in mothers during lactation raises concerns about the adverse consequences of treatment and the health of the child due to the distribution of drugs into breast milk. The following paper aims to present the safety profile of selected drug products during breastfeeding.